What does Co-Diagnostics, Inc. do?
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction…
What is Co-Diagnostics, Inc.'s P/E and P/B ratio?
Co-Diagnostics, Inc. has a P/E ratio of -0.0 and a P/B ratio of 0.31.
What is Co-Diagnostics, Inc.'s debt-to-equity ratio?
Co-Diagnostics, Inc. has a debt-to-equity ratio of 0.14.
How much does Co-Diagnostics, Inc. owe compared with what it owns?
Co-Diagnostics, Inc. owes $0.23 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Co-Diagnostics, Inc.'s Positivity rank?
Co-Diagnostics, Inc. is ranked #2,082 of 6,774 companies globally and #575 of 4,000 in United States on PositoAI, with a Positivity Score of 21,916.
Does Co-Diagnostics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Co-Diagnostics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 13 Jan 2026). It has no yellow flags.
Where can I read the latest news about Co-Diagnostics, Inc.?
Recent headlines about Co-Diagnostics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Co-Diagnostics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Co-Diagnostics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.